Medical Treatment Options for Diseases & Conditions - Drugs.com
Find your disease or condition and discover what medication options are available for you. Sort drugs by popularity, reviews and ratings.
6 Rare Diseases That Have New FDA-Approved Treatments
Feb 28, 2025 · An estimated 7,000 of these conditions have been identified, and more than 90% of them have no FDA-approved treatment. Yet progress toward developing such treatments …
Medical Conditions and Their Commonly Used Drugs - eMedExpert
Nov 7, 2017 · This list contains the names of many medical problems and the names of drugs that may be used for their treatment. The drugs are listed either as a generic name or drug class …
Treatment for Drug-Susceptible Tuberculosis Disease
Apr 17, 2025 · Treatment for drug-susceptible TB disease typically takes 4, 6, or 9 months depending on the regimen. Directly observed therapy (DOT) is the standard of care. The goal …
The most innovative new drugs and medicines of 2025 - Fast …
Mar 18, 2025 · For helping to slow Alzheimer’s-related cognitive decline The FDA approved Lilly’s Alzheimer’s drug, Kisunla, a monoclonal antibody treatment for early symptomatic Alzheimer’s …
What's new in drug therapy - UpToDate
Nov 21, 2025 · In August 2025, the US Food and Drug Administration approved semaglutide for treatment of MASH [57]. (See "Management of metabolic dysfunction-associated steatotic liver …
Pharmaceutical Therapy - Tampa General Hospital
Pharmaceutical Therapy When pharmaceutical drugs are used to treat or prevent disease, it is known as pharmaceutical therapy. Pharmaceutical therapy, also commonly referred to at …
U.S. FDA Approves Agios’ AQVESME™ (mitapivat) for the Treatment …
1 day ago · CAMBRIDGE, Mass., Dec. 23, 2025 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company focused on delivering …
Researchers Harness AI to Repurpose Existing Drugs for Treatment …
Sep 25, 2024 · The AI model, called TxGNN, is the first one developed specifically to identify drug candidates for rare diseases and conditions with no treatments. It identified drug candidates …
FDA approves first treatment for adults with complement 3 ...
Mar 20, 2025 · FDA approves first treatment for adults with complement 3 glomerulopathy, a rare kidney disease, to reduce proteinuria Action